In silico attempt for adduct agent(s) against malaria: Combination of chloroquine with alkaloids of Adhatoda vasica

Computer Methods and Programs in Biomedicine

Volumn 122, Issue 1, 2015, Pages 16-25

  Swain, Shasank S ^a   Sahu, Mahesh C ^a   Padhy, Rabindra N ^a  

^a SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

Author keywords

Adhatoda vasica; Alkaloids; Anti malarial adduct agent(s); Chloroquine; In silico study

Indexed keywords

DRUG THERAPY; METABOLITES; NITROGEN COMPOUNDS;

ADHATODA VASICA; ANTI-MALARIAL ADDUCT AGENT(S); ANTIMALARIAL DRUG; CHLOROQUINE; GLYCOLYTIC PATHWAYS; IN-SILICO; PLASMODIUM FALCIPARUM; TRIOSEPHOSPHATE ISOMERASE;

ALKALOIDS;

ACETYLQUININE; ADHATODINE; ALKALOID DERIVATIVE; ANISOTIN; ANTIMALARIAL AGENT; ARTEMISININ; CHLOROQUINE; CINCHONA ALKALOID; MEFLOQUINE; QUININE; QUININE DERIVATIVE; QUININE ETHYLCARBONATE; QUININE PHOSPHATE; QUININE VALERATE; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG; VASICINE; VASICINONE; VASICOLINONE; ALKALOID;

ANTIBIOTIC RESISTANCE; ANTIMALARIAL ACTIVITY; ARTICLE; COMPUTER MODEL; DRUG MECHANISM; DRUG STRUCTURE; GENE MUTATION; JUSTICIA ADHATODA; MALARIA; MALARIA CONTROL; MOLECULAR DOCKING; HUMAN; MALARIA, FALCIPARUM;

ALKALOIDS; CHLOROQUINE; HUMANS; MALARIA, FALCIPARUM;

EID: 84939566690     PISSN: 01692607     EISSN: 18727565     Source Type: Journal    
DOI: 10.1016/j.cmpb.2015.06.005     Document Type: Article

References (33)

1. Lal S., Sonal G.S., Phukan P.K. Status of malaria in India. J. Ind. Acad. Clin. Med. 2000, 5:19-23.
2. WHO Factsheet on the World Malaria report 2013, http://www.who.int/malaria/media/world_malaria_report_2013/en/ (assessed on September 2014).
3. Sharma V.P. Malaria and poverty in India. Curr. Sci. 2003, 80:513-514.
4. WHO Fact Sheet Number 94: Malaria 2014, http://www.who.int/mediacentre/factsheets/fs094/en/ updated March 2014 (assessed July 2014).
5. National Drug Policy on Malaria 2014, http://nvbdcp.gov.in/Doc/National-Drug-Policy-2013.pdf (assessed September 2014).
6. Dua V.K., Dev V., Phookan S., Gupta N.C., Sharma V.P., Subbarao K. Multidrug resistant Plasmodium falciparum malaria in Assam, India: timing of recurrence and anti-malarial drug concentrations in whole blood. Am. J. Trop. Med. Hyg. 2003, 69:555-557.
7. Shah N.K., Dhillon G.P., Dash A.P., Arora U., Meshnick S.R., Valecha N. Antimalarial drug resistance of Plasmodium falciparum in India: changes over time and space. Lancet Infect. Dis. 2011, 11:57-64.
8. Van Tyne D., Dieye B., Valim C., Daniels R.F., Sene P.D., et al. Changes in drug sensitivity and antimalaria drug resistance mutations over time among Plasmodium falciparum parasites in Senegal. Malaria J. 2013, 12:441. 10.1186/1475-2875-12-441.
9. Ross L.S., Gamo F.L., Lafuente-Monasterio M.J., Singh O.M., Rowland P., Wiegand R.C., Wirth D.F. In vitro resistance selections for Plasmodium falciparum dihydroorotate dehydrogenase inhibitors give mutations with multiple point mutations in the drug binding site and altered growth. J. Biol. Chem. 2014, 289:17980-17995.
10. Samanta M., Murthy M.R., Balaram H., Balaram P. Revisiting the mechanism of the triosephosphate isomerase reaction: the role of the fully conserved glutamic acid 97 residue. ChemBioChem 2011, 12:1886-1896.
11. Velanker S.S., Ray S.S., Gokhale R.S., Suma S., Balaram H., Balaram P., Murthy M.R.N. Triosephosphate isomerase from Plasmodium falciparum: the crystal structure provides insights into antimalarial drug design. Structure 1997, 5:751-761.
12. Ariey F., Witkowski B., Amaratunga C., Beghain J., Langlois A.C., Khim N., et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 2014, 505:50-55. 10.1038/nature12876.
13. WHO Guidelines for the Treatment of Malaria 2010, http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf?ua=1 (accessed June 2014).
14. Bloland P.B. Drug Resistance in Malaria WHO/CDS/CSR/DRS/2001.4 2001, http://www.who.int/csr/resources/publications/drugresist/malaria.pdf (accessed June 2014).
15. Ter Kuile F.O., Luxemburger C., Nosten F., Thwai K.L., Chongsuphajaisiddhi T., White N.J. Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 1995, 89:660-664.
16. Gobbi F., Rossanese A., Buonfrate D., Angheben A., Lunardi G., Bisoffi Z. Failure of malaria chemoprophylaxis with mefloquine in an oversize traveler to Mozambique. Malaria J. 2013, 12:451. 10.1186/1475-2875-12-451.
17. Howard M.A., Hibbard A.B., Terrell D.R., Medina P.J., Vesely S.K., George J.N. Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities. Proc. Bayl Univ. Med. Cent. 2003, 16:21-26.
18. Anvikar A.R., Sharma B., Sharma S.K., Ghosh S.K., Bhatt R.M., Kumar A., Mohanty S.S., Pillai C.R., Dash A.P., Valecha N. In vitro assessment of drug resistance in Plasmodium falciparum in five states of India. Indian J. Med. Res. 2012, 135:494-499.
19. Claeson U.P., Malmfors T., Wikman G., Bruhn J.G. Adhatoda vasica: a critical review of ethnopharmacological and toxicological data. J. Ethnopharmacol. 2000, 72:1-20.
20. Kamaraj C., Kaushik N.K., Rahuman A.A., Mohanakrishnan D., Bagavan A., Elango G., et al. Antimalarial activities of medicinal plants traditionally used in the villages of Dharmapuri regions of South India. J. Ethnopharmacol. 2010, 141:796-802.
21. Nagendrappa P.B., Naik M.P., Payyappallimana U. Ethnobotanical survey of malaria prophylactic remedies in Odisha, India. J. Ethnopharmacol. 2013, 146:768-772.
22. Rao M.R.K., Padhy R.N. A comprehensive study on the larvae of Aedes species in Angul district of Odisha, India: an approach to determine their habitat and prevalence in association with the ecology. J. Pharm. Biol. Sci. 2014, 9:98-109.
23. Guantai E., Chibale K. How can natural products serve as for a viable source of lead compounds for the development of new/novel anti-malarials?. Malaria J. 2011, 10(Suppl. 1):S2. 10.1186/1475-2875-10-S1-S2.
24. Jacob R.B., Andersen T., McDougal O.M. Accessible high-throughput virtual screening molecular docking software for students and educators. PLoS. Comput. Biol. 2012, 8:e1002499. 10.1371/journal.pcbi.1002499.
25. Ntie-Kang F., Onguéné P.A., Lifongo L.L., Ndom J.C., Sippl W., Mbaze L.M. The potential of antimalarial compounds derived from African medicinal plants: Part II. A pharmacological evaluation of non-alkaloids and non-terpenoids. Malaria J. 2014, 13:81. 10.1186/1475-2875-13-81.
26. Baelmans R., Deharo E., Bourdy G., Muñoz V., Quenevo C., Sauvain M., Ginsburg H. A search for natural bioactive compounds in Bolivia through a multidisciplinary approach: Part IV. Is a new haem polymerization inhibition test pertinent for the detection of antimalarial natural products?. J. Ethnopharmacol. 2000, 73:271-275.
27. Hill A.V. Vaccines against malaria. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2011, 366:2806-2814.
28. Sahu M.C., Patnaik R., Padhy R.N. In vitro combination-efficacy of ceftriaxone and leaf-extract of Combretum albidum G. Don against multidrug resistant Pseudomonas aeruginosa and host-toxicity testing with lymphocytes from human cord blood. J. Acute Med. 2014, 4:26-37.
29. Yu H.H., Kim K.J., Cha J.D., Kim H.K., Lee Y.E., Choi N.Y., You Y.O. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J. Med. Food. 2005, 8:454-461.
30. Prabhakar P.K., Doble M. Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes. Phytomedicine 2009, 16:1119-1126.
31. Nautiyal J., Kanwar S.S., Yu Y., Majumdar A.P.N. Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells. J. Mol. Signal. 2011, 6:7. http://www.jmolecular%20signaling.com/content/6/1/7.
32. AlKadi H.O. Antimalarial drug toxicity: a review. Chemotherapy 2007, 53:385-3891.
33. Vlahopoulos S., Critselis E., Voutsas I.F., Perez S.A., Moschovi M., Baxevanis C.N., Chrousos G.P. New use for old drugs?. Prospective targets of chloroquines in cancer therapy. Curr. Drug Targets 2014, 15:843-851.